Literature DB >> 29673825

Early Prediction of Poor Outcome Despite Successful Recanalization After Endovascular Treatment for Anterior Large Vessel Occlusion Stroke.

Huaiming Wang1, Meng Zhang2, Yonggang Hao3, Wenjie Zi4, Dong Yang4, Zhiming Zhou5, Yu Geng6, Zhen Wang7, Hua Li8, Gelin Xu4, Graeme J Hankey9, Yunyun Xiong10, Xinfeng Liu11.   

Abstract

OBJECTIVE: Successful recanalization (SR) of the occluded artery does not always translate into a good outcome for patients with acute anterior circulation large-vessel occlusion stroke. This study aimed to develop a scale to predict poor outcome early despite SR after endovascular treatment (EVT) for candidates identified using current guidelines.
METHODS: The eligible patients with SR were retrospectively enrolled between 2014 and 2016. Poor outcome was defined as modified Rankin Scale of 3 to 6 at 90 days. Multivariable logistic regression was used to derive a PooR outcomE of enDovascular treatment wIth suCcessful recanalizaTion (PREDICT) scale. The discrimination and calibration of the scale were assessed.
RESULTS: A total of 332 patients were enrolled. The PREDICT scale consisted of 5 items (prior intravenous thrombolysis, collateral status, blood glucose, blood neutrophil-to-lymphocyte ratio, and baseline National Institutes of Health Stroke Scale score). The scale had good discrimination and calibration. The risk of poor outcome was stratified into very low (PREDICT scale score ≤5), low (6-8), moderate (9-11), and high (≥12). Compared with patients with a score of ≤5, patients with a score of ≥12 had an 18.33-fold (95% confidence interval [CI], 6.36-52.89) increased risk of poor outcome.
CONCLUSIONS: The PREDICT scale is a practical tool for early prediction of poor outcome despite SR after EVT in our patients and, if validated in other patient populations, may serve as a scale for identifying which patients are most, and least, likely to benefit from EVT.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endovascular treatment; Outcome; Recanalization; Stroke

Mesh:

Year:  2018        PMID: 29673825     DOI: 10.1016/j.wneu.2018.04.042

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  7 in total

1.  Prognostic value of neutrophil to lymphocyte ratio in acute ischemic stroke after reperfusion therapy.

Authors:  Ying Bi; Jing Shen; Sheng-Cai Chen; Ji-Xiang Chen; Yuan-Peng Xia
Journal:  Sci Rep       Date:  2021-03-17       Impact factor: 4.379

2.  Metabolome of Cerebral Thrombi Reveals an Association between High Glycemia at Stroke Onset and Good Clinical Outcome.

Authors:  Laurent Suissa; Jean-Marie Guigonis; Fanny Graslin; Emilie Doche; Ophélie Osman; Yves Chau; Jacques Sedat; Sabine Lindenthal; Thierry Pourcher
Journal:  Metabolites       Date:  2020-11-25

3.  Association Between Blood Pressure Variability and Short-Term Outcome After Intra-arterial Thrombectomy in Acute Stroke Patients With Large-Vessel Occlusion.

Authors:  Mengqi Yang; Tao Lu; Baohui Weng; Yi He; Hong Yang
Journal:  Front Neurol       Date:  2021-01-11       Impact factor: 4.003

4.  Neutrophil-Lymphocyte ratio is associated with poor clinical outcome after mechanical thrombectomy in stroke in patients with COVID-19.

Authors:  Fawaz Al-Mufti; Priyank Khandelwal; Tolga Sursal; Jared B Cooper; Eric Feldstein; Krishna Amuluru; Jayaji M Moré; Ambooj Tiwari; Amit Singla; Adam A Dmytriw; Mariangela Piano; Luca Quilici; Guglielmo Pero; Leonardo Renieri; Nicola Limbucci; Mario Martínez-Galdámez; Miguel Schüller-Arteaga; Jorge Galván; Juan Francisco Arenillas-Lara; Zafar Hashim; Sanjeev Nayak; Keith Desousa; Hai Sun; Pankaj K Agarwalla; J Sudipta Roychowdhury; Emad Nourollahzadeh; Tannavi Prakash; Andrew R Xavier; J Diego Lozano; Gaurav Gupta; Dileep R Yavagal; Mohammad Elghanem; Chirag D Gandhi; Stephan A Mayer
Journal:  Interv Neuroradiol       Date:  2022-04-11       Impact factor: 1.610

5.  Association Between Neutrophil-to-Lymphocyte Ratio/Lymphocyte-to-Monocyte Ratio and In-Hospital Clinical Outcomes in Ischemic Stroke Treated with Intravenous Thrombolysis.

Authors:  Yunyun Xiong; Xingquan Zhao; Guangshuo Li; Yahui Hao; Chuanying Wang; Shang Wang
Journal:  J Inflamm Res       Date:  2022-09-24

6.  Association between CHADS2, CHA2DS2-VASc, ATRIA, and Essen Stroke Risk Scores and Functional Outcomes in Acute Ischemic Stroke Patients Who Received Endovascular Thrombectomy.

Authors:  Hyung Jun Kim; Moo-Seok Park; Joonsang Yoo; Young Dae Kim; Hyungjong Park; Byung Moon Kim; Oh Young Bang; Hyeon Chang Kim; Euna Han; Dong Joon Kim; JoonNyung Heo; Jin Kyo Choi; Kyung-Yul Lee; Hye Sun Lee; Dong Hoon Shin; Hye-Yeon Choi; Sung-Il Sohn; Jeong-Ho Hong; Jong Yun Lee; Jang-Hyun Baek; Gyu Sik Kim; Woo-Keun Seo; Jong-Won Chung; Seo Hyun Kim; Sang Won Han; Joong Hyun Park; Jinkwon Kim; Yo Han Jung; Han-Jin Cho; Seong Hwan Ahn; Sung Ik Lee; Kwon-Duk Seo; Yoonkyung Chang; Hyo Suk Nam; Tae-Jin Song
Journal:  J Clin Med       Date:  2022-09-23       Impact factor: 4.964

7.  Nomogram to Predict Mortality of Endovascular Thrombectomy for Ischemic Stroke Despite Successful Recanalization.

Authors:  Xiaohao Zhang; Kang Yuan; Huaiming Wang; Pengyu Gong; Teng Jiang; Yi Xie; Lei Sheng; Dezhi Liu; Xinfeng Liu; Gelin Xu
Journal:  J Am Heart Assoc       Date:  2020-01-24       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.